P. Grützmacher

1.1k total citations
48 papers, 674 citations indexed

About

P. Grützmacher is a scholar working on Surgery, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Grützmacher has authored 48 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 14 papers in Hematology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Grützmacher's work include Lipoproteins and Cardiovascular Health (19 papers), Erythropoietin and Anemia Treatment (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). P. Grützmacher is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Erythropoietin and Anemia Treatment (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). P. Grützmacher collaborates with scholars based in Germany, France and Japan. P. Grützmacher's co-authors include W. Schoeppe, Winfried März, H. W. Radtke, Gross Wl, Bernd Peschke, Ulrich Julius, Volker Schettler, Franz Heigl, E. Roeseler and C. Keller and has published in prestigious journals such as Kidney International, Atherosclerosis and Nephrology Dialysis Transplantation.

In The Last Decade

P. Grützmacher

44 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Grützmacher Germany 14 295 253 179 143 130 48 674
T. Eisenhauer Germany 14 438 1.5× 103 0.4× 67 0.4× 192 1.3× 181 1.4× 38 789
M. Barthels Germany 15 308 1.0× 429 1.7× 70 0.4× 317 2.2× 38 0.3× 67 1.0k
Sabrina Paoletti Italy 14 202 0.7× 162 0.6× 392 2.2× 55 0.4× 29 0.2× 19 628
Ignacio Alberca Spain 18 85 0.3× 495 2.0× 47 0.3× 150 1.0× 59 0.5× 40 818
Jocelyn S. Garland Canada 16 117 0.4× 89 0.4× 372 2.1× 117 0.8× 61 0.5× 30 812
Matthias Hoke Austria 15 151 0.5× 106 0.4× 85 0.5× 168 1.2× 71 0.5× 30 667
Margareta Sten-Linder Sweden 15 157 0.5× 476 1.9× 44 0.2× 583 4.1× 42 0.3× 31 1.1k
Kouzou Minamikawa Japan 14 147 0.5× 339 1.3× 38 0.2× 138 1.0× 41 0.3× 24 606
Giuliano Boscutti Italy 14 259 0.9× 36 0.1× 235 1.3× 87 0.6× 147 1.1× 37 679
Mark Jesky United Kingdom 16 97 0.3× 76 0.3× 221 1.2× 60 0.4× 35 0.3× 23 603

Countries citing papers authored by P. Grützmacher

Since Specialization
Citations

This map shows the geographic impact of P. Grützmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Grützmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Grützmacher more than expected).

Fields of papers citing papers by P. Grützmacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Grützmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Grützmacher. The network helps show where P. Grützmacher may publish in the future.

Co-authorship network of co-authors of P. Grützmacher

This figure shows the co-authorship network connecting the top 25 collaborators of P. Grützmacher. A scholar is included among the top collaborators of P. Grützmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Grützmacher. P. Grützmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schettler, Volker, Christian Peter, Thomas Zimmermann, et al.. (2022). The German Lipoprotein Apheresis Registry—Summary of the ninth annual report. Therapeutic Apheresis and Dialysis. 26(S1). 81–88. 13 indexed citations
2.
Schettler, Volker, C. Neumann, Christian Peter, et al.. (2017). Current insights into the German Lipoprotein Apheresis Registry (GLAR) – Almost 5 years on. Atherosclerosis Supplements. 30. 50–55. 19 indexed citations
3.
Schettler, Volker, et al.. (2017). Extrem niedrige LDL-Cholesterinkonzentrationen durch moderne lipidsenkende Therapien. CardioVasc. 17(4). 54–57. 1 indexed citations
4.
Grützmacher, P., et al.. (2017). Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a). PubMed. 12(S1). 22–26. 5 indexed citations
5.
Heigl, Franz, Tobias Pflederer, Volker Schettler, et al.. (2017). Lipidological competence centres and networks: Future perspectives to improve healthcare of patients with disorders of lipid metabolism. Atherosclerosis Supplements. 30. 63–71. 4 indexed citations
6.
Hatzinger, Martin, et al.. (2016). Die Geschichte der Nierentransplantation. Der Urologe. 55(10). 1353–1359. 22 indexed citations
7.
Grützmacher, P., et al.. (2015). Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias. PubMed. 10(S1). 2–7. 7 indexed citations
8.
Schettler, Volker, et al.. (2015). Differenzierung der Indikation zur Lipoproteinapherese bei erhöhtem Lp(a) durch unterschiedliche Messmethoden. CardioVasc. 15(3). 36–38. 4 indexed citations
9.
Kurz, Peter, P. Roth, E. Werner, et al.. (1995). Differences in calcium kinetic pattern between CAPD and HD patients.. PubMed. 44(4). 255–61. 18 indexed citations
10.
Landgraf, H., et al.. (1994). Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.. PubMed. 2(7). 393–7. 2 indexed citations
11.
12.
Grützmacher, P., et al.. (1993). Decrease in Peritonitis Rate by Integrated Disconnect System in Patients on Continuous Ambulatory Peritoneal Dialysis. Peritoneal Dialysis International. 13(2_suppl). 326–328. 5 indexed citations
13.
Kurz, Peter, et al.. (1992). Factors Influencing Transperitoneal Calcium Balance During CAPD. ASAIO Journal. 38(3). M589–M592. 5 indexed citations
14.
Grützmacher, P., P. Roth, E. Werner, et al.. (1992). Effect of recombinant human erythropoietin on iron balance in maintenance hemodialysis: theoretical considerations, clinical experience and consequences.. PubMed. 38 Suppl 1. S92–7. 9 indexed citations
15.
Grützmacher, P., C. Vallbracht, Ernst‐Heinrich Scheuermann, Peter Kurz, & W. Schoeppe. (1992). Combined LDL apheresis and hemodialysis in a patient with end-stage renal disease and accelerated coronary atherosclerosis.. PubMed. 37(3). M435–6.
16.
Grützmacher, P., et al.. (1990). Treatment with Recombinant Human Erythropoietin in Patients with Aluminum Overload and Hyperparathyroidism. Blood Purification. 8(5). 279–284. 9 indexed citations
17.
Bergmann, Martin, et al.. (1990). Iron Metabolism under rEPO Therapy in Patients on Maintenance Hemodialysis. The International Journal of Artificial Organs. 13(2). 109–112. 3 indexed citations
18.
Grützmacher, P., et al.. (1989). Echocardiographic findings in patients on maintenance hemodialysis substituted with recombinant human erythropoietin.. PubMed. 31(1). 26–30. 65 indexed citations
19.
Grützmacher, P., et al.. (1988). Lipoproteins and Apolipoproteins during the Progression of Chronic Renal Disease. ˜The œNephron journals/Nephron journals. 50(2). 103–111. 56 indexed citations
20.
Nonnast-Daniel, B., et al.. (1988). Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.. PubMed. 66. 94–103. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Eisenhauer Breakdown of academic impact, for papers by M. Barthels Breakdown of academic impact, for papers by Sabrina Paoletti Breakdown of academic impact, for papers by Ignacio Alberca Breakdown of academic impact, for papers by Jocelyn S. Garland Breakdown of academic impact, for papers by Matthias Hoke Breakdown of academic impact, for papers by Margareta Sten-Linder Breakdown of academic impact, for papers by Kouzou Minamikawa Breakdown of academic impact, for papers by Giuliano Boscutti Breakdown of academic impact, for papers by Mark Jesky
Rankless by CCL
2026